Association between 1,5-Anhydroglucitol and Acute C Peptide Response to Arginine among Patients with Type 2 Diabetes

<div>Odds ratios of decreased <i>β</i>-cell function by 1,5-anhydroglucitol as continuous variables. Adjustments were made for sex, diabetes duration, BMI, SBP, TG, LDL-c, HDL-c, eGFR, and glucose-lowering treatments other than insulin. 1,5-Anhydroglucitol was transformed by logarithm before analysis.</div>

Journal of Diabetes Research

fig2

Figure 2

Figure 2: Association between 1,5-Anhydroglucitol and Acute C Peptide Response to Arginine among Patients with Type 2 Diabetes 